View Filing Data

Excludes 1,036,665 shares of common stock held by directors and officers, and any stockholders whose ownership exceeds five percent of the shares outstanding, at June 30, 2009. Exclusion of shares held by any person should not be construed to indicate that such person possesses the power, directly or indirectly, to direct or cause the direction of the management or policies of the registrant, or that such person is controlled by or under common control with the registrant.

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2010	Jun. 30, 2009
Revenues:
Product sales	$ 3,613	$ 3,634	$ 7,141	$ 6,872
Other revenues	191	79	255	149
Total revenues	3,804	3,713	7,396	7,021
Operating expenses:
Cost of sales (excludes amortization of certain acquired intangible assets presented below)	553	531	1,061	1,008
Research and development	675	693	1,321	1,326
Selling, general and administrative	986	910	1,870	1,708
Amortization of certain acquired intangible assets	73	73	147	147
Other	0	49	(1)	54
Total operating expenses	2,287	2,256	4,398	4,243
Operating income	1,517	1,457	2,998	2,778
Interest expense, net	147	150	292	297
Interest and other income, net	94	50	178	108
Income before income taxes	1,464	1,357	2,884	2,589
Provision for income taxes	262	88	515	301
Net income	$ 1,202	$ 1,269	$ 2,369	$ 2,288
Earnings per share:
Basic	$ 1.25	$ 1.25	$ 2.44	$ 2.24
Diluted	$ 1.25	$ 1.25	$ 2.43	$ 2.23
Shares used in calculation of earnings per share:
Basic	959	1,013	970	1,023
Diluted	964	1,017	976	1,027

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2010	Dec. 31, 2009
Current assets:
Cash and cash equivalents	$ 1,712	$ 2,884
Marketable securities	12,811	10,558
Trade receivables, net	2,208	2,109
Inventories	2,112	2,220
Other current assets	1,321	1,161
Total current assets	20,164	18,932
Property, plant and equipment, net	5,630	5,738
Intangible assets, net	2,421	2,567
Goodwill	11,334	11,335
Other assets	1,251	1,057
Total assets	40,800	39,629
Current liabilities:
Accounts payable	722	574
Accrued liabilities	2,856	3,299
Current portion of convertible notes	2,414	0
Total current liabilities	5,992	3,873
Convertible notes	2,232	4,512
Other long-term debt	7,086	6,089
Other non-current liabilities	$ 2,320	$ 2,488
Contingencies and commitments
Stockholders' equity:
Common stock and additional paid-in capital; $0.0001 par value; 2,750 shares authorized; outstanding - 958 shares in 2010 and 995 shares in 2009	$ 27,119	$ 26,944
Accumulated deficit	(4,266)	(4,322)
Accumulated other comprehensive income	317	45
Total stockholders' equity	23,170	22,667
Total liabilities and stockholders' equity	$ 40,800	$ 39,629

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Millions	Jun. 30, 2010	Dec. 31, 2009
Stockholders' equity:
Common stock and additional paid-in capital, par value	$ 0.0001	$ 0.0001
Common stock and additional paid-in capital, shares authorized	2,750	2,750
Common stock and additional paid-in capital, shares outstanding	958	995

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2010	Jun. 30, 2009
Cash flows from operating activities:
Net income	$ 2,369	$ 2,288
Depreciation and amortization	503	520
Stock-based compensation expense	166	123
Other items, net	72	111
Changes in operating assets and liabilities:
Trade receivables, net	(99)	(108)
Inventories	120	50
Other current assets	(129)	(48)
Accounts payable	148	48
Accrued income taxes	(297)	(79)
Other accrued liabilities	(376)	(367)
Net cash provided by operating activities	2,477	2,538
Cash flows from investing activities:
Purchases of property, plant and equipment	(271)	(256)
Purchases of marketable securities	(7,607)	(7,483)
Proceeds from sales of marketable securities	5,246	5,365
Proceeds from maturities of marketable securities	290	964
Other	(48)	(32)
Net cash used in investing activities	(2,390)	(1,442)
Cash flows from financing activities:
Repurchases of common stock	(2,300)	(1,997)
Net proceeds from issuance of debt	989	1,980
Net proceeds from issuance of common stock in connection with the Company's equity award programs	54	97
Other	(2)	18
Net cash (used in) provided by financing activities	(1,259)	98
(Decrease) increase in cash and cash equivalents	(1,172)	1,194
Cash and cash equivalents at beginning of period	2,884	1,774
Cash and cash equivalents at end of period	$ 1,712	$ 2,968

Summary of significant accounting policies	6 Months Ended
Summary of significant accounting policies	Jun. 30, 2010
Summary of significant accounting policies [Abstract]
Summary of significant accounting policies	1. Summary of significant accounting policies Business Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” or “us”) is a global biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. We concentrate on innovating novel medicines based on advances in cellular and molecular biology and we operate in one business segment, human therapeutics. Basis of presentation The financial information for the three and six months ended June 30, 2010 and 2009 is unaudited but includes all adjustments (consisting of only normal recurring adjustments, unless otherwise indicated), which Amgen considers necessary for a fair presentation of its consolidated results of operations for those periods. Interim results are not necessarily indicative of results for the full fiscal year. The condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2009 and our condensed consolidated financial statements in our Quarterly Report on Form 10-Q for the three months ended March 31, 2010. Principles of consolidation The condensed consolidated financial statements include the accounts of Amgen as well as its wholly owned subsidiaries. We do not have any significant interests in any variable interest entities. All material intercompany transactions and balances have been eliminated in consolidation. Use of estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates. Property, plant and equipment, net Property, plant and equipment are recorded at historical cost, net of accumulated depreciation of $4.9 billion and $4.6 billion as of June 30, 2010 and December 31, 2009, respectively. Fair value measurement In January 2010, we adopted a newly issued accounting standard which requires additional disclosure about the amounts of and reasons for significant transfers between levels of the fair value hierarchy discussed in Note 8, “Fair value measurement.” This standard also clarifies existing disclosure requirements related to the level of disaggregation of fair value measurements for each class of assets and liabilities and disclosures about inputs and valuation techniques used to measure fair value for both recurring and nonrecurring Level 2 and Level 3 measurements. As this accounting standard only requires enhanced disclosure, the adoption of this standard did not impact our financial position, results of operations or cash flows. In addition, effective for interim and annual periods beginning after December 15, 2010, this standard will require additional disclosure and require an entity to present disaggregated information about activity in Level 3 fair value measurements on a gross basis, rather than a single amount.

Income taxes	6 Months Ended
Income taxes	Jun. 30, 2010
Income taxes [Abstract]
Income taxes	2. Income taxes The effective tax rates for the three and six months ended June 30, 2010 and June 30, 2009 are different from the statutory rate primarily as a result of indefinitely invested earnings of our foreign operations. In addition, the effective tax rates for the three and six months ended June 30, 2009 were further reduced by the favorable resolution of certain non-routine transfer pricing matters with the Internal Revenue Service (“IRS”) for prior periods. We do not provide for U.S. income taxes on undistributed earnings of our foreign operations that are intended to be invested indefinitely outside the United States. One or more of our legal entities file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and certain foreign jurisdictions and our income tax returns are routinely audited by the tax authorities in those jurisdictions. Significant disputes can arise with these tax authorities involving the timing and amount of deductions, the use of tax credits and allocations of income among various tax jurisdictions because of differing interpretations of tax laws and regulations. We are no longer subject to U.S. federal income tax examinations for years ending on or before December 31, 2004 or to California state income tax examinations for years ending on or before December 31, 2003. The IRS is currently examining our U.S. income tax returns for the years ended December 31, 2007 and 2008. As of June 30, 2010, the Company and the IRS have agreed to certain transfer pricing adjustments for the years ended December 31, 2007 and 2008 and the Company has accordingly adjusted its liability for unrecognized tax benefits (“UTBs”) as discussed below. The remainder of this examination is expected to be completed in 2011. During the three and six months ended June 30, 2010, the gross amount of our UTBs increased by approximately $55 million and $130 million, respectively, as a result of tax positions taken during the current year. During the three and six months ended June 30, 2010, the gross amount of our UTBs decreased by approximately $375 million primarily as a result of resolving certain transfer pricing matters related to prior years. Substantially all of our UTBs as of June 30, 2010, if recognized, would affect our effective tax rate. The Company does not expect any significant changes to its UTBs during the next twelve months.

Earnings per share

6 Months Ended

Jun. 30, 2010

Earnings per share [Abstract]

Earnings per share

3. Earnings per share

The computation of basic earnings per share (“EPS”) is based upon the weighted-average number of our common shares outstanding. The computation of diluted EPS is based upon the weighted-average number of our common shares and potential dilutive common shares outstanding. Potential common shares outstanding, determined using the treasury stock method, principally include: stock options, restricted stock units and other equity awards under our employee compensation plans; our 2011 Convertible Notes, 2013 Convertible Notes and 2032 Modified Convertible Notes, as discussed below; and our outstanding warrants (collectively “dilutive securities”). The convertible note hedges purchased in connection with the issuance of our 2011 Convertible Notes and 2013 Convertible Notes are excluded from the calculation of diluted EPS as their impact is always anti-dilutive.

Upon conversion of our 2011 Convertible Notes, 2013 Convertible Notes and 2032 Modified Convertible Notes, the principal amount or accreted value would be settled in cash and the excess of the conversion value, as defined, over the principal amount or accreted value may be settled in cash and/or shares of our common stock. Therefore, only the shares of our common stock potentially issuable with respect to the excess of the notes’ conversion value over their principal amount or accreted value, if any, are considered as dilutive potential common shares for purposes of calculating diluted EPS.

The following table sets forth the computation for basic and diluted EPS (in millions, except per share information):


	Three months ended				Six months ended
	June 30,				June 30,
	2010		2009		2010		2009
Income (Numerator):
Net income for basic and diluted EPS	$	1,202	$	1,269	$	2,369	$	2,288


Shares (Denominator):
Weighted-average shares for basic EPS		959		1,013		970		1,023
Effect of dilutive securities		5		4		6		4

Weighted-average shares for diluted EPS		964		1,017		976		1,027


Basic EPS	$	1.25	$	1.25	$	2.44	$	2.24
Diluted EPS	$	1.25	$	1.25	$	2.43	$	2.23

For the three and six months ended June 30, 2010, there were employee stock options, calculated on a weighted average basis, to purchase 46 million and 43 million shares of our common stock, respectively, with exercise prices greater than the average market prices of our common stock for these periods that are not included in the computation of diluted EPS as their impact would have been anti-dilutive. For the three and six months ended June 30, 2009, there were employee stock options, calculated on a weighted average basis, to purchase 51 million and 48 million shares of our common stock, respectively, with exercise prices greater than the average market prices of our common stock for these periods that are not included in the computation of diluted EPS as their impact would have been anti-dilutive. In addition, shares of our common stock, which may be issued upon conversion of our convertible debt or upon exercise of our warrants, are not included in the computation of diluted EPS for any of the periods presented above as their impact on diluted EPS would have been anti-dilutive. Shares which may be issued under our 2010 performance award plan were also excluded because conditions under the plan were not met.

Available-for-sale securities

6 Months Ended

Jun. 30, 2010

Available-for-sale securities [Abstract]

Available-for-sale securities

4. Available-for-sale securities

The fair values of available-for-sale investments by type of security, contractual maturity and classification in the Condensed Consolidated Balance Sheets are as follows (in millions):


			Gross		Gross			Estimated
	Amortized		unrealized		unrealized			fair
June 30, 2010	cost		gains		losses			value
Type of security:
U.S. Treasury securities	$	3,762	$	69	$	—		$	3,831
Other government related debt securities:
Obligations of U.S. government agencies and FDIC guaranteed bank debt		2,833		73		—			2,906
Foreign and other		982		16		—			998
Corporate debt securities:
Financial		1,680		38		(3	)		1,715
Industrial		2,103		74		(8	)		2,169
Other		278		9		—			287
Mortgage and asset backed securities		701		6		(2	)		705
Money market mutual funds		1,544		—		—			1,544
Other short-term interest bearing securities		253		—		—			253

Total debt securities		14,136		285		(13	)		14,408
Equity securities		50		—		(9	)		41

	$	14,186	$	285	$	(22	)	$	14,449


			Gross		Gross			Estimated
	Amortized		unrealized		unrealized			fair
December 31, 2009	cost		gains		losses			value
Type of security:
U.S. Treasury securities	$	1,929	$	12	$	(6	)	$	1,935
Obligations of U.S. government agencies and FDIC guaranteed bank debt		3,731		62		(1	)		3,792
Corporate debt securities		4,193		96		(4	)		4,285
Mortgage and asset backed securities		489		4		(2	)		491
Money market mutual funds		2,784		—		—			2,784
Other short-term interest bearing securities		55		—		—			55

Total debt securities		13,181		174		(13	)		13,342
Equity securities		63		—		(8	)		55

	$	13,244	$	174	$	(21	)	$	13,397


	June 30,		December 31,
Contractual maturity	2010		2009
Maturing in one year or less	$	3,187	$	3,444
Maturing after one year through three years		5,860		6,369
Maturing after three years through five years		4,841		3,207
Maturing after five years		520		322

Total debt securities		14,408		13,342
Equity securities		41		55

	$	14,449	$	13,397


	June 30,			December 31,
Classification in the Condensed Consolidated Balance Sheets	2010			2009
Cash and cash equivalents	$	1,712		$	2,884
Marketable securities		12,811			10,558
Other assets — noncurrent		41			55

		14,564			13,497
Less cash		(115	)		(100	)

	$	14,449		$	13,397

For the three months ended June 30, 2010 and 2009, realized gains totaled $36 million and $26 million, respectively, and realized losses totaled $2 million and $15 million, respectively. For the six months ended June 30, 2010 and 2009, realized gains totaled $58 million and $60 million, respectively, and realized losses totaled $3 million and $48 million, respectively. The cost of securities sold is based on the specific identification method.

The primary objectives of our investment portfolio are liquidity and safety of principal. Investments are made with the objective of achieving the highest rate of return consistent with these two objectives. Our investment policy limits debt security investments to certain types of debt and money market instruments issued by institutions primarily with investment grade credit ratings and places restrictions on maturities and concentration by type and issuer.

We review our available-for-sale securities for other-than-temporary declines in fair value below their cost basis on a quarterly basis and whenever events or changes in circumstances indicate that the cost basis of an asset may not be recoverable. This evaluation is based on a number of factors including, the length of time and extent to which the fair value has been below our cost basis and adverse conditions specifically related to the security including any changes to the credit rating of the security by a rating agency. As of June 30, 2010 and December 31, 2009, we believe that the cost bases for our available-for-sale securities were recoverable in all material respects.

Inventories

6 Months Ended

Jun. 30, 2010

Inventories [Abstract]

Inventories

5. Inventories

Inventories consisted of the following (in millions):


	June 30,		December 31,
	2010		2009
Raw materials	$	127	$	97
Work in process		1,521		1,683
Finished goods		464		440

	$	2,112	$	2,220

Financing arrangements

6 Months Ended

Jun. 30, 2010

Financing arrangements [Abstract]

Financing arrangements

6. Financing arrangements

The following table reflects the carrying value of our borrowings under our various financing arrangements (dollar amounts in millions):


	June 30,			December 31,
	2010			2009
0.125% convertible notes due February 2011 (2011 Convertible Notes)	$	2,414		$	2,342
0.375% convertible notes due 2013 (2013 Convertible Notes)		2,150			2,088
5.85% notes due 2017 (2017 Notes)		1,099			1,099
4.85% notes due 2014 (2014 Notes)		1,000			1,000
5.70% notes due 2019 (2019 Notes)		998			998
6.40% notes due 2039 (2039 Notes)		996			995
6.375% notes due 2037 (2037 Notes)		899			899
5.75% notes due 2040 (2040 Notes)		696			—
6.15% notes due 2018 (2018 Notes)		499			499
6.90% notes due 2038 (2038 Notes)		499			499
4.50% notes due 2020 (2020 Notes)		300			—
Zero-coupon modified convertible notes due in 2032 (2032 Modified Convertible Notes)		82			82
8.125% notes due 2097 (Other)		100			100

Total borrowings		11,732			10,601
Less current portion (2011 Convertible Notes)		(2,414	)		—

Total non-current debt	$	9,318		$	10,601

2020 Notes and 2040 Notes

In March 2010, we issued $700 million aggregate principal amount of notes due in 2040 (the “2040 Notes”) and $300 million aggregate principal amount of notes due in 2020 (the “2020 Notes”) in a registered offering. The 2040 Notes and 2020 Notes pay interest at fixed annual rates of 5.75% and 4.50%, respectively. The 2040 Notes and 2020 Notes may be redeemed at any time at our option, in whole or in part, at an amount equal to the outstanding principal amount of the notes being redeemed plus accrued and unpaid interest, if any, and a “make-whole” amount, as defined. Upon the occurrence of a change in control triggering event, as defined, we may be required to purchase, for cash, all or a portion of the 2040 Notes and the 2020 Notes at a price equal to 101% of the principal amount of the notes plus accrued and unpaid interest. Debt issuance costs incurred in connection with the issuance of this debt totaled approximately $7 million and are being amortized over the lives of the notes.

2017 Notes

In March 2010, we entered into interest rate swap agreements that effectively convert a fixed rate interest coupon to a London Interbank Offered Rate (“LIBOR”)-based floating rate coupon over the remaining life of the 2017 notes.

Stockholders' equity

6 Months Ended

Jun. 30, 2010

Stockholders' equity [Abstract]

Stockholders' equity

7. Stockholders’ equity

Stock repurchase program

A summary of activity under our stock repurchase program is as follows (in millions):


	2010				2009
	Shares		Dollars		Shares		Dollars
First quarter		29.1	$	1,684		37.5	$	1,997
Second quarter		10.3		616		—		—

Total		39.4	$	2,300		37.5	$	1,997

In December 2009, the Board of Directors authorized us to repurchase up to an additional $5.0 billion of common stock of which a total of $3.7 billion remains available for stock repurchases as of June 30, 2010. The manner of purchases, the amount we spend and the number of shares repurchased will vary based on a variety of factors, including the stock price, blackout periods in which we are restricted from repurchasing shares, and our credit rating and may include private block purchases as well as market transactions.

Fair value measurement

6 Months Ended

Jun. 30, 2010

Fair value measurement [Abstract]

Fair value measurement

8. Fair value measurement

We use various valuation approaches in determining the fair value of our financial assets and liabilities within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy is broken down into three levels based on the source of inputs as follows:


Level 1	—	Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access

Level 2	—	Valuations for which all significant inputs are observable, either directly or indirectly, other than level 1 inputs

Level 3	—	Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary among the various types of financial assets and liabilities. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level of input used that is significant to the overall fair value measurement.

The following fair value hierarchy tables present information about each major class/category of the Company’s financial assets and liabilities measured at fair value on a recurring basis (in millions):


	Fair value measurement at June 30, 2010 using:
	Quoted prices in		Significant		Significant
	active markets for		other observable		unobservable
	identical assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Available-for-sale securities:
U.S. Treasury securities	$	3,831	$	—	$	—	$	3,831
Other government related debt securities:
Obligations of U.S. government agencies and FDIC guaranteed bank debt		—		2,906		—		2,906
Foreign and other		—		998		—		998

Total other government related debt securities		—		3,904		—		3,904
Corporate debt securities:
Financial		—		1,715		—		1,715
Industrial		—		2,169		—		2,169
Other		—		287		—		287

Total corporate debt securities		—		4,171		—		4,171
Mortgage and asset backed securities		—		705		—		705
Money market mutual funds		1,544		—		—		1,544
Other short-term interest bearing securities		—		253		—		253
Equity securities		41		—		—		41

Total available-for-sale securities		5,416		9,033		—		14,449

Derivatives:
Foreign exchange contracts		—		328		—		328
Interest rate swap contracts		—		214		—		214

Total derivatives		—		542		—		542


Total assets	$	5,416	$	9,575	$	—	$	14,991


Liabilities:
Derivatives:
Foreign exchange contracts	$	—	$	46	$	—	$	46

Total derivatives		—		46		—		46

Total liabilities	$	—	$	46	$	—	$	46


	Fair value measurement at December 31, 2009 using:
	Quoted prices in		Significant		Significant
	active markets for		other observable		unobservable
	identical assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Available-for-sale securities:
U.S. Treasury securities	$	1,935	$	—	$	—	$	1,935
Obligations of U.S. government agencies and FDIC guaranteed bank debt		—		3,792		—		3,792
Corporate debt securities		—		4,285		—		4,285
Mortgage and asset backed securities		—		491		—		491
Money market mutual funds		2,784		—		—		2,784
Other short-term interest bearing securities		—		55		—		55
Equity securities		55		—		—		55

Total available-for-sale securities		4,774		8,623		—		13,397
Derivatives		—		153		—		153

Total assets	$	4,774	$	8,776	$	—	$	13,550


Liabilities:
Derivatives	$	—	$	152	$	—	$	152

Total liabilities	$	—	$	152	$	—	$	152

Our U.S. Treasury securities, money market mutual funds and equity securities are valued using quoted market prices in active markets with no valuation adjustment. We value our U.S. Treasury securities and money market mutual funds taking into consideration valuations obtained from a third-party pricing service.

Substantially all of our other government related and corporate debt securities are investment grade with maturity dates of five years or less. Our government related debt securities portfolio is comprised of securities with a weighted average credit rating of “AAA” or equivalent by Standard and Poor’s (“S&P”), Moody’s Investors Services, Inc. (“Moody’s”) or Fitch, Inc. (“Fitch”), and our corporate debt securities portfolio has a weighted average credit rating of “A” or equivalent by S&P, Moody’s or Fitch. We value these securities taking into consideration valuations obtained from third-party pricing services. The pricing services utilize industry standard valuation models, including both income and market based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker/dealer quotes of the same or similar securities, issuer credit spreads, benchmark securities and other observable inputs.

Our mortgage and asset backed securities portfolio is comprised entirely of senior tranches, with a credit rating of “AAA” or equivalent by S&P, Moody’s or Fitch. We value these securities taking into consideration valuations obtained from third-party pricing services. The pricing services utilize industry standard valuation models, including both income and market based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker/dealer quotes of the same or similar securities, issuer credit spreads, benchmark securities, prepayment/default projections based on historical data and other observable inputs.

We value our other short-term interest bearing securities at amortized cost which approximates fair value given their near term maturity dates.

Substantially all of our foreign currency forward and option contracts have maturities of three years or less and all are entered into with counterparties that have a minimum credit rating of “A-” or equivalent by S&P, Moody’s or Fitch. We value these securities taking into consideration valuations obtained from a third-party valuation service that utilizes an income-based industry standard valuation model for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include quoted foreign currency spot rates, forward points, LIBOR and swap curves and obligor credit default swap rates. In addition, inputs for our foreign currency option contracts also include implied volatility measures. These inputs, where applicable, are at commonly quoted intervals. As of June 30, 2010 and December 31, 2009, we had open foreign currency forward contracts with notional amounts of $3.2 billion and $3.4 billion, respectively, and open option contracts with notional amounts of $419 million and $376 million, respectively, that were primarily Euro-based and were designated as cash flow hedges. In addition, as of June 30, 2010 and December 31, 2009, we had $566 million and $414 million, respectively, of foreign currency forward contracts to reduce exposure to fluctuations in value of certain assets and liabilities denominated in foreign currencies that were primarily Euro-based and that were not designated as hedges (see Note 9, “Derivative instruments”).

Our interest rate swap contracts are entered into with counterparties that have a minimum credit rating of “A-” or equivalent by S&P, Moody’s or Fitch. We value these contracts using an income-based industry standard valuation model for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include LIBOR and swap curves and obligor credit default swap rates. We had interest rate swap agreements with an aggregate notional amount of $2.6 billion and $1.5 billion as of June 30, 2010 and December 31, 2009, respectively, that were designated as fair value hedges (see Note 9, “Derivative instruments”).

There have been no transfers of assets or liabilities between the fair value measurement levels and there were no material remeasurements to fair value during the six months ended June 30, 2010 and 2009 of assets and liabilities that are not measured at fair value on a recurring basis.

Summary of the fair value of other financial instruments

Short-term assets and liabilities

The estimated fair values of cash equivalents, accounts receivable and accounts payable approximate their carrying values due to the short-term nature of these financial instruments.

Borrowings

The following tables present the carrying values and estimated fair values of our convertible notes, modified convertible notes and other long-term notes payable. We value our convertible and modified convertible notes using an income-based industry standard valuation model for which all significant inputs are observable, either directly or indirectly, including benchmark yields adjusted for our credit risk, to estimate fair value (Level 2). We value our other long-term notes using quoted prices (Level 2). The fair values of our convertible notes and modified convertible notes exclude their equity components and represent only the liability components of these instruments as their equity components are included in “Common stock and additional paid-in capital” in the Condensed Consolidated Balance Sheets (in millions):


	June 30, 2010
	Carrying value		Fair value
2011 Convertible Notes	$	2,414	$	2,491
2013 Convertible Notes		2,150		2,451
2017 Notes		1,099		1,275
2014 Notes		1,000		1,116
2019 Notes		998		1,160
2039 Notes		996		1,175
2037 Notes		899		1,036
2040 Notes		696		761
2018 Notes		499		587
2038 Notes		499		619
2020 Notes		300		321
2032 Modified Convertible Notes		82		83
Other		100		135

Total	$	11,732	$	13,210


	December 31, 2009
	Carrying value		Fair value
2011 Convertible Notes	$	2,342	$	2,487
2013 Convertible Notes		2,088		2,374
2017 Notes		1,099		1,207
2014 Notes		1,000		1,075
2019 Notes		998		1,077
2039 Notes		995		1,102
2037 Notes		899		988
2018 Notes		499		551
2038 Notes		499		582
2032 Modified Convertible Notes		82		81
Other		100		125

Total	$	10,601	$	11,649

Derivative instruments

6 Months Ended

Jun. 30, 2010

Derivative instruments [Abstract]

Derivative instruments

9. Derivative instruments

The Company is exposed to risks related to its business operations, certain of which are managed through derivative instruments. The risks that we manage by using derivative instruments are foreign exchange rate risk and interest rate risk. We use financial instruments including foreign currency forward, foreign currency option, forward interest rate and interest rate swap contracts to reduce our risk to these exposures. We do not use derivatives for speculative trading purposes.

We recognize all of our derivative instruments as either assets or liabilities at fair value in the Condensed Consolidated Balance Sheets (see Note 8, “Fair value measurement”). The accounting for changes in the fair value of a derivative instrument depends on whether it has been formally designated and qualifies as part of a hedging relationship under the applicable accounting standards and, further, on the type of hedging relationship. For derivatives formally designated as hedges, we assess both at inception and quarterly thereafter, whether the hedging derivatives are highly effective in offsetting changes in either the fair value or cash flows of the hedged item. Our derivatives that are not designated and do not qualify as hedges are adjusted to fair value through current earnings.

Cash flow hedges

We are exposed to possible changes in values of certain anticipated foreign currency cash flows resulting from changes in foreign currency exchange rates, primarily associated with our international product sales denominated in Euros. Increases or decreases in the cash flows associated with our international product sales due to movements in foreign currency exchange rates are partially offset by the corresponding increases and decreases in our international operating expenses resulting from these foreign currency exchange rate movements. To further reduce our exposure to foreign currency exchange rate fluctuations on our international product sales, we enter into foreign currency forward and option contracts to hedge a portion of our projected international product sales primarily over a three-year time horizon with, at any given point in time, a higher percentage of nearer term projected product sales being hedged than successive periods. As of June 30, 2010 and December 31, 2009, we had open foreign currency forward contracts with notional amounts of $3.2 billion and $3.4 billion, respectively, and open option contracts with notional amounts of $419 million and $376 million, respectively. These foreign currency forward and option contracts, primarily Euro-based, have been designated as cash flow hedges, and accordingly, the effective portion of the unrealized gains and losses on these contracts are reported in Accumulated Other Comprehensive Income (“AOCI”) in the Condensed Consolidated Balance Sheets and reclassified to earnings in the same periods during which the hedged transactions affect earnings.

In connection with the anticipated issuance of long-term fixed-rate debt, we occasionally enter into forward interest rate contracts in order to hedge the variability in cash flows due to changes in the applicable Treasury rate between the time we enter into these contracts and the time the related debt is issued. Gains and losses on such contracts, which are designated as cash flow hedges, are recorded in Other Comprehensive Income (“OCI”) and amortized into earnings over the lives of the associated debt issuances.

The following table reflects the effective portion of the unrealized gain/(loss) recognized in OCI for our cash flow hedge contracts (in millions):


	Three months ended					Six months ended
	June 30,					June 30,
Derivatives in cash flow hedging relationships	2010		2009			2010		2009
Foreign exchange contracts	$	224	$	(100	)	$	399	$	(77	)
Forward interest rate contracts		—		—			—		(11	)

Total	$	224	$	(100	)	$	399	$	(88	)

The following table reflects the location in the Condensed Consolidated Statements of Income and the effective portion of the gain/(loss) reclassified from AOCI into earnings for our cash flow hedge contracts (in millions):


		Three months ended				Six months ended
Derivatives in cash flow		June 30,				June 30,
hedging relationships	Statements of income location	2010		2009		2010		2009
Foreign exchange contracts	Product sales	$	21	$	10	$	15	$	29
Forward interest rate contracts	Interest expense, net		—		—		—		—

Total		$	21	$	10	$	15	$	29

No portions of our cash flow hedge contracts are excluded from the assessment of hedge effectiveness and the ineffective portions of these hedging instruments resulted in approximately $1 million of income recorded in “Interest and other income, net” in the Condensed Consolidated Statements of Income for both the three and six months ended June 30, 2010. The ineffective portions of these hedging instruments resulted in an aggregate expense of approximately $1 million recorded in “Interest and other income, net” and “Interest expense, net” in the Condensed Consolidated Statements of Income for both the three and six months ended June 30, 2009. As of June 30, 2010, the amounts expected to be reclassified from AOCI into earnings over the next 12 months are approximately $130 million of gains on foreign currency forward and option contracts and approximately $1 million of losses on forward interest rate contracts.

Fair value hedges

To achieve a desired mix of fixed and floating interest rate debt, we have entered into interest rate swap agreements, which qualify and have been designated as fair value hedges. The terms of these interest rate swap agreements correspond to the related hedged debt instruments and effectively convert a fixed interest rate coupon to a LIBOR-based floating rate coupon over the lives of the respective notes. We had interest rate swap agreements with aggregate notional amounts of $2.6 billion and $1.5 billion as of June 30, 2010 and December 31, 2009, respectively. The interest rate swap agreements as of June 30, 2010 were for our notes due in 2014, 2017 and 2018 and, as of December 31, 2009 for our notes due in 2014 and 2018. For derivative instruments that are designated and qualify as a fair value hedge, the unrealized gain or loss on the derivative as well as the offsetting unrealized loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. For the three and six months ended June 30, 2010, we included the unrealized losses on the hedged debt of $107 million and $124 million, respectively, in the same line item, “Interest expense, net” in the Condensed Consolidated Statements of Income, as the offsetting unrealized gains of $107 million and $124 million, respectively, on the related interest rate swap agreements. For the three and six months ended June 30, 2009, we included the unrealized gains on the hedged debt of $41 million and $103 million, respectively, in the same line item, “Interest expense, net” in the Condensed Consolidated Statements of Income, as the offsetting unrealized losses of $41 million and $103 million, respectively, on the related interest rate swap agreements.

Derivatives not designated as hedges

We enter into foreign currency forward contracts to reduce our exposure to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies which are not designated as hedging transactions. These exposures are hedged on a month-to-month basis. As of June 30, 2010 and December 31, 2009, the total notional amounts of these foreign currency forward contracts, primarily Euro-based, were $566 million and $414 million, respectively.

The following table reflects the location in the Condensed Consolidated Statements of Income and the amount of gain (loss) recognized in income for the derivative instruments not designated as hedging instruments (in millions):


		Three months ended					Six months ended
Derivatives not designated as		June 30,					June 30,
hedging instruments	Statements of income location	2010		2009			2010		2009
Foreign exchange contracts	Interest and other income, net	$	53	$	(10	)	$	76	$	4

Classification in the Condensed Consolidated Balance Sheets

The following tables reflect the fair values of both derivatives designated as hedging instruments and not designated as hedging instruments included in the Condensed Consolidated Balance Sheets as of June 30, 2010 and December 31, 2009 (in millions):


	Derivative assets			Derivative liabilities
	Balance Sheet location	Fair value		Balance Sheet location	Fair value
Derivatives designated as hedging instruments as of June 30, 2010:
Interest rate swap contracts	Other current assets/ Other non-current assets	$	214	Accrued liabilities/ Other non-current liabilities	$	—
Foreign exchange contracts	Other current assets/ Other non-current assets		328	Accrued liabilities/ Other non-current liabilities		46

Total derivatives designated as hedging instruments			542			46

Derivatives not designated as hedging instruments as of June 30, 2010:
Foreign exchange contracts	Other current assets		—	Accrued liabilities		—

Total derivatives not designated as hedging instruments			—			—

Total derivatives		$	542		$	46


	Derivative assets			Derivative liabilities
	Balance Sheet location	Fair value		Balance Sheet location	Fair value
Derivatives designated as hedging instruments as of December 31, 2009:
Interest rate swap contracts	Other current assets/ Other non-current assets	$	90	Accrued liabilities/ Other non-current liabilities	$	—
Foreign exchange contracts	Other current assets/ Other non-current assets		63	Accrued liabilities/ Other non-current liabilities		152

Total derivatives designated as hedging instruments			153			152

Derivatives not designated as hedging instruments as of December 31, 2009:
Foreign exchange contracts	Other current assets		—	Accrued liabilities		—

Total derivatives not designated as hedging instruments			—			—

Total derivatives		$	153		$	152

Our derivative contracts that were in a liability position as of June 30, 2010 contain certain credit risk related contingent provisions that are triggered if (i) we were to undergo a change in control and (ii) our or the surviving entity’s creditworthiness deteriorates, which is generally defined as having either a credit rating that is below investment grade or a materially weaker creditworthiness after the change in control. If these events were to occur, the counterparties would have the right, but not the obligation, to close the contracts under early termination provisions. In such circumstances, the counterparties could request immediate settlement of these contracts for amounts that approximate the then current fair values of the contracts.

Contingencies and commitments	6 Months Ended
Contingencies and commitments	Jun. 30, 2010
Contingencies and commitments [Abstract]
Contingencies and commitments	10. Contingencies and commitments In the ordinary course of business, we are involved in various legal proceedings and other matters, including those discussed in this Note, which are complex in nature and have outcomes that are difficult to predict. We record accruals for such contingencies to the extent that we conclude that it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. While it is not possible to accurately predict or determine the eventual outcome of these items, one or more of these items currently pending could have a material adverse effect on our consolidated results of operations, financial position or cash flows. Certain of our legal proceedings and other matters are discussed below: Teva Matters Sensipar^{^®} Abbreviated New Drug Application (“ANDA”) Litigation On July 16, 2010, the U.S. District Court for the District of Delaware (the “Delaware District Court”) vacated its previous scheduling order, including the September 1, 2010 date for the case to enter the trial pool. The Delaware District Court entered a new scheduling order directed to expert discovery and notifying the parties that after August 31, 2010 the court will schedule another status conference. Simonian v. Amgen Inc. On June 8, 2010 the U.S. District Court for the Northern District of Illinois granted Amgen’s motion to stay the case. A status hearing has been scheduled for September 16, 2010. Average Wholesale Price (“AWP”) Litigation State of Kansas, ex rel Steve Six v. Amgen Inc. and Immunex Corporation. On May 16, 2010, Amgen and Immunex reached a settlement with the state of Kansas, and, on May 24, 2010, both companies were dismissed from the matter. Birch v. Sharer, et al. On June 30, 2010, Amgen filed its demurrer to plaintiff’s complaint with the Complex Division of the Los Angeles Superior Court. The court will hear oral argument on the parties’ demurrers on September 13, 2010. ERISA Litigation On June 16, 2010, the U.S. District Court for the Central District of California entered an order dismissing the entire lawsuit with prejudice. On June 24, 2010, the plaintiffs filed a notice of appeal with the U.S. Court of Appeals for the Ninth Circuit. Petitioner’s opening brief and excerpts of record shall be served and filed by December 6, 2010, and respondent’s answering brief and excerpts of record shall be served and filed by January 5, 2011. Qui Tam Actions On May 7, 2010, the relator filed two motions with the U.S. District Court for the District of Massachusetts (the “Massachusetts District Court”), one for reconsideration of the Massachusetts District Court’s dismissal and one for leave to file an amended complaint. On May 26, 2010, the Massachusetts District Court denied the relator’s motion for reconsideration but granted leave to file a fourth amended complaint. On May 24, 2010, the states of New York, Massachusetts, Michigan, California, Illinois, and Indiana (the “States”) filed notices of intent to appeal the Massachusetts District Court’s judgment to the U.S. Court of Appeals for the First Circuit. On June 9, 2010, the States filed a motion for certification under rule 54(b) to ensure that they have an appealable order and the Massachusetts District Court granted the motion. On June 11, 2010, the Massachusetts District Court held a scheduling conference related to relator’s fourth amended complaint and ordered that a jury trial be set for the running trial list starting on July 5, 2011. On June 28, 2010, Amgen filed motions to dismiss five non-conspiracy counts and one conspiracy count in the relator’s fourth amended complaint and a hearing on the motions to dismiss was held by the Massachusetts District Court on July 21, 2010. Following oral argument, the Massachusetts District Court denied, from the bench, Amgen’s motions to dismiss and indicated that a written ruling would follow. Other Eastern District of New York Subpoenas Amgen continues to cooperate with the government’s document requests. Additionally, numerous current and former Amgen employees have and continue to receive civil and grand jury subpoenas to provide testimony on a wide variety of subjects. Western District of Washington Subpoenas Amgen continues to cooperate with the government’s document requests. Additionally, numerous current and former Amgen employees, including some executive vice presidents and other officers of the Company, have and continue to receive grand jury subpoenas to provide testimony on a wide variety of subjects.

Summary of significant accounting policies (Policies)	6 Months Ended
Summary of significant accounting policies (Policies)	Jun. 30, 2010
Summary of significant accounting policies (Policies) [Abstract]
Business	Business Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” or “us”) is a global biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. We concentrate on innovating novel medicines based on advances in cellular and molecular biology and we operate in one business segment, human therapeutics.
Basis of presentation	Basis of presentation The financial information for the three and six months ended June 30, 2010 and 2009 is unaudited but includes all adjustments (consisting of only normal recurring adjustments, unless otherwise indicated), which Amgen considers necessary for a fair presentation of its consolidated results of operations for those periods. Interim results are not necessarily indicative of results for the full fiscal year. The condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2009 and our condensed consolidated financial statements in our Quarterly Report on Form 10-Q for the three months ended March 31, 2010.
Principles of consolidation	Principles of consolidation The condensed consolidated financial statements include the accounts of Amgen as well as its wholly owned subsidiaries. We do not have any significant interests in any variable interest entities. All material intercompany transactions and balances have been eliminated in consolidation.
Use of estimates	Use of estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates.
Property, plant and equipment, net	Property, plant and equipment, net Property, plant and equipment are recorded at historical cost, net of accumulated depreciation of $4.9 billion and $4.6 billion as of June 30, 2010 and December 31, 2009, respectively.
Fair value measurement	Fair value measurement In January 2010, we adopted a newly issued accounting standard which requires additional disclosure about the amounts of and reasons for significant transfers between levels of the fair value hierarchy discussed in Note 8, “Fair value measurement.” This standard also clarifies existing disclosure requirements related to the level of disaggregation of fair value measurements for each class of assets and liabilities and disclosures about inputs and valuation techniques used to measure fair value for both recurring and nonrecurring Level 2 and Level 3 measurements. As this accounting standard only requires enhanced disclosure, the adoption of this standard did not impact our financial position, results of operations or cash flows. In addition, effective for interim and annual periods beginning after December 15, 2010, this standard will require additional disclosure and require an entity to present disaggregated information about activity in Level 3 fair value measurements on a gross basis, rather than a single amount.

Earnings per share (Tables)

6 Months Ended

Jun. 30, 2010

Earnings per share (Tables) [Abstract]

Computation of basic and diluted EPS

The following table sets forth the computation for basic and diluted EPS (in millions, except per share information):


	Three months ended				Six months ended
	June 30,				June 30,
	2010		2009		2010		2009
Income (Numerator):
Net income for basic and diluted EPS	$	1,202	$	1,269	$	2,369	$	2,288


Shares (Denominator):
Weighted-average shares for basic EPS		959		1,013		970		1,023
Effect of dilutive securities		5		4		6		4

Weighted-average shares for diluted EPS		964		1,017		976		1,027


Basic EPS	$	1.25	$	1.25	$	2.44	$	2.24
Diluted EPS	$	1.25	$	1.25	$	2.43	$	2.23

Available-for-sale securities (Tables)

6 Months Ended

Jun. 30, 2010

Available-for-sale securities (Tables) [Abstract]

Fair values of available-for-sale investments by type of security

The fair values of available-for-sale investments by type of security, contractual maturity and classification in the Condensed Consolidated Balance Sheets are as follows (in millions):


			Gross		Gross			Estimated
	Amortized		unrealized		unrealized			fair
June 30, 2010	cost		gains		losses			value
Type of security:
U.S. Treasury securities	$	3,762	$	69	$	—		$	3,831
Other government related debt securities:
Obligations of U.S. government agencies and FDIC guaranteed bank debt		2,833		73		—			2,906
Foreign and other		982		16		—			998
Corporate debt securities:
Financial		1,680		38		(3	)		1,715
Industrial		2,103		74		(8	)		2,169
Other		278		9		—			287
Mortgage and asset backed securities		701		6		(2	)		705
Money market mutual funds		1,544		—		—			1,544
Other short-term interest bearing securities		253		—		—			253

Total debt securities		14,136		285		(13	)		14,408
Equity securities		50		—		(9	)		41

	$	14,186	$	285	$	(22	)	$	14,449


			Gross		Gross			Estimated
	Amortized		unrealized		unrealized			fair
December 31, 2009	cost		gains		losses			value
Type of security:
U.S. Treasury securities	$	1,929	$	12	$	(6	)	$	1,935
Obligations of U.S. government agencies and FDIC guaranteed bank debt		3,731		62		(1	)		3,792
Corporate debt securities		4,193		96		(4	)		4,285
Mortgage and asset backed securities		489		4		(2	)		491
Money market mutual funds		2,784		—		—			2,784
Other short-term interest bearing securities		55		—		—			55

Total debt securities		13,181		174		(13	)		13,342
Equity securities		63		—		(8	)		55

	$	13,244	$	174	$	(21	)	$	13,397

Fair values of available-for-sale investments by contractual maturity


	June 30,		December 31,
Contractual maturity	2010		2009
Maturing in one year or less	$	3,187	$	3,444
Maturing after one year through three years		5,860		6,369
Maturing after three years through five years		4,841		3,207
Maturing after five years		520		322

Total debt securities		14,408		13,342
Equity securities		41		55

	$	14,449	$	13,397

Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets


	June 30,			December 31,
Classification in the Condensed Consolidated Balance Sheets	2010			2009
Cash and cash equivalents	$	1,712		$	2,884
Marketable securities		12,811			10,558
Other assets — noncurrent		41			55

		14,564			13,497
Less cash		(115	)		(100	)

	$	14,449		$	13,397

Inventories (Tables)

6 Months Ended

Jun. 30, 2010

Inventories (Tables) [Abstract]

Inventories

Inventories consisted of the following (in millions):


	June 30,		December 31,
	2010		2009
Raw materials	$	127	$	97
Work in process		1,521		1,683
Finished goods		464		440

	$	2,112	$	2,220

Financing arrangements (Tables)

6 Months Ended

Jun. 30, 2010

Financing arrangements (Tables) [Abstract]

Carrying value of borrowings

The following table reflects the carrying value of our borrowings under our various financing arrangements (dollar amounts in millions):


	June 30,			December 31,
	2010			2009
0.125% convertible notes due February 2011 (2011 Convertible Notes)	$	2,414		$	2,342
0.375% convertible notes due 2013 (2013 Convertible Notes)		2,150			2,088
5.85% notes due 2017 (2017 Notes)		1,099			1,099
4.85% notes due 2014 (2014 Notes)		1,000			1,000
5.70% notes due 2019 (2019 Notes)		998			998
6.40% notes due 2039 (2039 Notes)		996			995
6.375% notes due 2037 (2037 Notes)		899			899
5.75% notes due 2040 (2040 Notes)		696			—
6.15% notes due 2018 (2018 Notes)		499			499
6.90% notes due 2038 (2038 Notes)		499			499
4.50% notes due 2020 (2020 Notes)		300			—
Zero-coupon modified convertible notes due in 2032 (2032 Modified Convertible Notes)		82			82
8.125% notes due 2097 (Other)		100			100

Total borrowings		11,732			10,601
Less current portion (2011 Convertible Notes)		(2,414	)		—

Total non-current debt	$	9,318		$	10,601

Stockholders' equity (Tables)

6 Months Ended

Jun. 30, 2010

Stockholders' equity (Tables) [Abstract]

Stock repurchase program

A summary of activity under our stock repurchase program is as follows (in millions):


	2010				2009
	Shares		Dollars		Shares		Dollars
First quarter		29.1	$	1,684		37.5	$	1,997
Second quarter		10.3		616		—		—

Total		39.4	$	2,300		37.5	$	1,997

Fair value measurement (Tables)

6 Months Ended

Jun. 30, 2010

Fair value measurement (Tables) [Abstract]

Major class/category of the companys' financial assets and liabilities measured at fair value on a recurring basis


	Fair value measurement at June 30, 2010 using:
	Quoted prices in		Significant		Significant
	active markets for		other observable		unobservable
	identical assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Available-for-sale securities:
U.S. Treasury securities	$	3,831	$	—	$	—	$	3,831
Other government related debt securities:
Obligations of U.S. government agencies and FDIC guaranteed bank debt		—		2,906		—		2,906
Foreign and other		—		998		—		998

Total other government related debt securities		—		3,904		—		3,904
Corporate debt securities:
Financial		—		1,715		—		1,715
Industrial		—		2,169		—		2,169
Other		—		287		—		287

Total corporate debt securities		—		4,171		—		4,171
Mortgage and asset backed securities		—		705		—		705
Money market mutual funds		1,544		—		—		1,544
Other short-term interest bearing securities		—		253		—		253
Equity securities		41		—		—		41

Total available-for-sale securities		5,416		9,033		—		14,449

Derivatives:
Foreign exchange contracts		—		328		—		328
Interest rate swap contracts		—		214		—		214

Total derivatives		—		542		—		542


Total assets	$	5,416	$	9,575	$	—	$	14,991


Liabilities:
Derivatives:
Foreign exchange contracts	$	—	$	46	$	—	$	46

Total derivatives		—		46		—		46

Total liabilities	$	—	$	46	$	—	$	46


	Fair value measurement at December 31, 2009 using:
	Quoted prices in		Significant		Significant
	active markets for		other observable		unobservable
	identical assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Available-for-sale securities:
U.S. Treasury securities	$	1,935	$	—	$	—	$	1,935
Obligations of U.S. government agencies and FDIC guaranteed bank debt		—		3,792		—		3,792
Corporate debt securities		—		4,285		—		4,285
Mortgage and asset backed securities		—		491		—		491
Money market mutual funds		2,784		—		—		2,784
Other short-term interest bearing securities		—		55		—		55
Equity securities		55		—		—		55

Total available-for-sale securities		4,774		8,623		—		13,397
Derivatives		—		153		—		153

Total assets	$	4,774	$	8,776	$	—	$	13,550


Liabilities:
Derivatives	$	—	$	152	$	—	$	152

Total liabilities	$	—	$	152	$	—	$	152

Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes

The fair values of our convertible notes and modified convertible notes exclude their equity components and represent only the liability components of these instruments as their equity components are included in “Common stock and additional paid-in capital” in the Condensed Consolidated Balance Sheets (in millions):


	June 30, 2010
	Carrying value		Fair value
2011 Convertible Notes	$	2,414	$	2,491
2013 Convertible Notes		2,150		2,451
2017 Notes		1,099		1,275
2014 Notes		1,000		1,116
2019 Notes		998		1,160
2039 Notes		996		1,175
2037 Notes		899		1,036
2040 Notes		696		761
2018 Notes		499		587
2038 Notes		499		619
2020 Notes		300		321
2032 Modified Convertible Notes		82		83
Other		100		135

Total	$	11,732	$	13,210


	December 31, 2009
	Carrying value		Fair value
2011 Convertible Notes	$	2,342	$	2,487
2013 Convertible Notes		2,088		2,374
2017 Notes		1,099		1,207
2014 Notes		1,000		1,075
2019 Notes		998		1,077
2039 Notes		995		1,102
2037 Notes		899		988
2018 Notes		499		551
2038 Notes		499		582
2032 Modified Convertible Notes		82		81
Other		100		125

Total	$	10,601	$	11,649

Derivative instruments (Tables)

6 Months Ended

Jun. 30, 2010

Derivative instruments (Tables) [Abstract]

Effective portion of the unrealized gain/(loss) recognized in other comprehensive income for our cash flow hedge contracts

The following table reflects the effective portion of the unrealized gain/(loss) recognized in OCI for our cash flow hedge contracts (in millions):


	Three months ended					Six months ended
	June 30,					June 30,
Derivatives in cash flow hedging relationships	2010		2009			2010		2009
Foreign exchange contracts	$	224	$	(100	)	$	399	$	(77	)
Forward interest rate contracts		—		—			—		(11	)

Total	$	224	$	(100	)	$	399	$	(88	)

Condensed consolidated statements of income and effective portion of gain/(loss) reclassified from accumulated other comprehensive income into income for our cash flow hedge contracts


		Three months ended				Six months ended
Derivatives in cash flow		June 30,				June 30,
hedging relationships	Statements of income location	2010		2009		2010		2009
Foreign exchange contracts	Product sales	$	21	$	10	$	15	$	29
Forward interest rate contracts	Interest expense, net		—		—		—		—

Total		$	21	$	10	$	15	$	29

Condensed consolidated statements of income and the amount of gain recognized in income for the derivative instruments not designated as hedging instruments


		Three months ended					Six months ended
Derivatives not designated as		June 30,					June 30,
hedging instruments	Statements of income location	2010		2009			2010		2009
Foreign exchange contracts	Interest and other income, net	$	53	$	(10	)	$	76	$	4

Fair values of both derivatives designated as hedging instruments and not designated as hedging instruments included in condensed consolidated balance sheets


	Derivative assets			Derivative liabilities
	Balance Sheet location	Fair value		Balance Sheet location	Fair value
Derivatives designated as hedging instruments as of June 30, 2010:
Interest rate swap contracts	Other current assets/ Other non-current assets	$	214	Accrued liabilities/ Other non-current liabilities	$	—
Foreign exchange contracts	Other current assets/ Other non-current assets		328	Accrued liabilities/ Other non-current liabilities		46

Total derivatives designated as hedging instruments			542			46

Derivatives not designated as hedging instruments as of June 30, 2010:
Foreign exchange contracts	Other current assets		—	Accrued liabilities		—

Total derivatives not designated as hedging instruments			—			—

Total derivatives		$	542		$	46


	Derivative assets			Derivative liabilities
	Balance Sheet location	Fair value		Balance Sheet location	Fair value
Derivatives designated as hedging instruments as of December 31, 2009:
Interest rate swap contracts	Other current assets/ Other non-current assets	$	90	Accrued liabilities/ Other non-current liabilities	$	—
Foreign exchange contracts	Other current assets/ Other non-current assets		63	Accrued liabilities/ Other non-current liabilities		152

Total derivatives designated as hedging instruments			153			152

Derivatives not designated as hedging instruments as of December 31, 2009:
Foreign exchange contracts	Other current assets		—	Accrued liabilities		—

Total derivatives not designated as hedging instruments			—			—

Total derivatives		$	153		$	152

Summary of significant accounting policies (Details) - USD ($) $ in Billions	Jun. 30, 2010	Dec. 31, 2009
Summary of significant accounting policies (Textuals) [Abstract]
Accumulated depreciation on property, plant and equipment	$ 4.9	$ 4.6

Income taxes (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
Income taxes (Details) - USD ($) $ in Millions	Jun. 30, 2010	Jun. 30, 2010
Income taxes (Textuals) [Abstract]
Increase in gross unrecognized tax benefits for period	$ 55	$ 130
Decrease in gross amount of unrecognized tax benefits for period	$ 375	$ 375

Earnings per share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2010	Jun. 30, 2009
Income (Numerator):
Net income for basic and diluted EPS	$ 1,202	$ 1,269	$ 2,369	$ 2,288
Shares (Denominator):
Weighted-average shares for basic EPS	959	1,013	970	1,023
Effect of dilutive securities	5	4	6	4
Weighted-average shares for diluted EPS	964	1,017	976	1,027
Basic EPS	$ 1.25	$ 1.25	$ 2.44	$ 2.24
Diluted EPS	$ 1.25	$ 1.25	$ 2.43	$ 2.23
Earnings per share (Textuals) [Abstract]
Antidilutive securities excluded from computation of earnings per share, amount	46	51	43	48

Available-for-sale securities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2010	Jun. 30, 2009	Dec. 31, 2009	Dec. 31, 2008
Fair values of available-for-sale investments by type of security
Amortized cost	$ 14,186		$ 14,186		$ 13,244
Gross unrealized gains			285		174
Gross unrealized losses			(22)		(21)
Estimated fair value	14,449		14,449		13,397
Fair values of available-for-sale investments by contractual maturity
Maturing in one year or less	3,187		3,187		3,444
Maturing after one year through three years	5,860		5,860		6,369
Maturing after three years through five years	4,841		4,841		3,207
Maturing after five years	520		520		322
Total	14,449		14,449		13,397
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Cash and cash equivalents	1,712	$ 2,968	1,712	$ 2,968	2,884	$ 1,774
Marketable securities	12,811		12,811		10,558
Other assets - noncurrent	41		41		55
Total including cash	14,564		14,564		13,497
Less cash	(115)		(115)		(100)
Total	14,449		14,449		13,397
Available-for-sale securities (Textuals) [Abstract]
Total realized gains	36	26	58	60
Total realized losses	2	$ 15	3	$ 48
US Treasury securities [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	3,762		3,762		1,929
Gross unrealized gains			69		12
Gross unrealized losses			0		(6)
Estimated fair value	3,831		3,831		1,935
Fair values of available-for-sale investments by contractual maturity
Total	3,831		3,831		1,935
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	3,831		3,831		1,935
Obligations of U.S. government agencies and FDIC guaranteed bank debt [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	2,833		2,833		3,731
Gross unrealized gains			73		62
Gross unrealized losses			0		(1)
Estimated fair value	2,906		2,906		3,792
Fair values of available-for-sale investments by contractual maturity
Total	2,906		2,906		3,792
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	2,906		2,906		3,792
Other government related debt securities - Foreign and other [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	982		982
Gross unrealized gains			16
Gross unrealized losses			0
Estimated fair value	998		998
Fair values of available-for-sale investments by contractual maturity
Total	998		998
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	998		998
Corporate debt securities [Member]
Fair values of available-for-sale investments by type of security
Amortized cost					4,193
Gross unrealized gains					96
Gross unrealized losses					(4)
Estimated fair value	4,171		4,171		4,285
Fair values of available-for-sale investments by contractual maturity
Total	4,171		4,171		4,285
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	4,171		4,171		4,285
Corporate debt securities - Financial [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	1,680		1,680
Gross unrealized gains			38
Gross unrealized losses			(3)
Estimated fair value	1,715		1,715
Fair values of available-for-sale investments by contractual maturity
Total	1,715		1,715
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	1,715		1,715
Corporate debt securities - Industrial [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	2,103		2,103
Gross unrealized gains			74
Gross unrealized losses			(8)
Estimated fair value	2,169		2,169
Fair values of available-for-sale investments by contractual maturity
Total	2,169		2,169
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	2,169		2,169
Corporate debt securities - Other [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	278		278
Gross unrealized gains			9
Gross unrealized losses			0
Estimated fair value	287		287
Fair values of available-for-sale investments by contractual maturity
Total	287		287
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	287		287
Mortgage and asset backed securities [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	701		701		489
Gross unrealized gains			6		4
Gross unrealized losses			(2)		(2)
Estimated fair value	705		705		491
Fair values of available-for-sale investments by contractual maturity
Total	705		705		491
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	705		705		491
Money market mutual funds [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	1,544		1,544		2,784
Gross unrealized gains			0		0
Gross unrealized losses			0		0
Estimated fair value	1,544		1,544		2,784
Fair values of available-for-sale investments by contractual maturity
Total	1,544		1,544		2,784
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	1,544		1,544		2,784
Other short-term interest bearing securities [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	253		253		55
Gross unrealized gains			0		0
Gross unrealized losses			0		0
Estimated fair value	253		253		55
Fair values of available-for-sale investments by contractual maturity
Total	253		253		55
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	253		253		55
Total debt securities [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	14,136		14,136		13,181
Gross unrealized gains			285		174
Gross unrealized losses			(13)		(13)
Estimated fair value	14,408		14,408		13,342
Fair values of available-for-sale investments by contractual maturity
Total	14,408		14,408		13,342
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	14,408		14,408		13,342
Equity securities [Member]
Fair values of available-for-sale investments by type of security
Amortized cost	50		50		63
Gross unrealized gains			0		0
Gross unrealized losses			(9)		(8)
Estimated fair value	41		41		55
Fair values of available-for-sale investments by contractual maturity
Total	41		41		55
Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets
Total	$ 41		$ 41		$ 55

Inventories (Details) - USD ($) $ in Millions	Jun. 30, 2010	Dec. 31, 2009
Inventories
Raw materials	$ 127	$ 97
Work in process	1,521	1,683
Finished goods	464	440
Inventories	$ 2,112	$ 2,220

Financing arrangements (Details) $ in Millions	6 Months Ended
Financing arrangements (Details) $ in Millions	Jun. 30, 2010 USD ($)	Dec. 31, 2009 USD ($)
Carrying value of borrowings
Convertible notes current	$ 2,414	$ 0
Convertible notes	2,232	4,512
Notes payable	7,086	6,089
Total borrowings	11,732	10,601
Less current portion (2011 Convertible Notes)	(2,414)	0
Total non-current debt	9,318	10,601
0.125% convertible notes due February 2011 (2011 Convertible notes) [Member]
Carrying value of borrowings
Convertible notes current	2,414
Convertible notes		$ 2,342
Less current portion (2011 Convertible Notes)	$ (2,414)
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	0.125%	0.125%
0.375% convertible notes due 2013 (2013 Convertible notes) [Member]
Carrying value of borrowings
Convertible notes	$ 2,150	$ 2,088
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	0.375%	0.375%
5.85% notes due 2017 (2017 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 1,099	$ 1,099
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	5.85%	5.85%
4.85% notes due 2014 (2014 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 1,000	$ 1,000
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	4.85%	4.85%
5.70% notes due 2019 (2019 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 998	$ 998
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	5.70%	5.70%
6.40% notes due 2039 (2039 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 996	$ 995
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	6.40%	6.40%
6.375% notes due 2037 (2037 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 899	$ 899
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	6.375%	6.375%
5.75% notes due 2040 (2040 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 696	$ 0
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	5.75%
Aggregate principal amount of notes issued	$ 700
Percentage of principal amount of notes that may be paid upon the occurrence of a change in control triggering event	1.01
6.15% notes due 2018 (2018 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 499	$ 499
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	6.15%	6.15%
6.90% notes due 2038 (2038 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 499	$ 499
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	6.90%	6.90%
4.50% notes due 2020 (2020 Notes) [Member]
Carrying value of borrowings
Notes payable	$ 300	$ 0
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	4.50%
Aggregate principal amount of notes issued	$ 300
Percentage of principal amount of notes that may be paid upon the occurrence of a change in control triggering event	1.01
Zero-coupon modified convertible notes due in 2032 (2032 Modified convertible notes) [Member]
Carrying value of borrowings
Convertible notes	$ 82	$ 82
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	0.00%	0.00%
8.125% notes due 2097 (Other) [Member]
Carrying value of borrowings
Notes payable	$ 100	$ 100
Financing arrangements (Textuals) [Abstract]
Stated contractual interest rate on note	8.125%	8.125%
5.75% notes due 2040 (2040 Notes) and 4.50% notes due 2020 (2020 Notes) [Member]
Financing arrangements (Textuals) [Abstract]
Total debt issuance costs	$ 7

Stockholders' equity (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
Stockholders' equity (Details) - USD ($) $ in Millions	Jun. 30, 2010	Mar. 31, 2010	Jun. 30, 2009	Mar. 31, 2009	Jun. 30, 2010	Jun. 30, 2009	Dec. 04, 2009
Stock repurchase program
Stock repurchase, shares	10,300,000	29,100,000	0	37,500,000	39,400,000	37,500,000
Stock repurchase, value	$ 616	$ 1,684	$ 0	$ 1,997	$ 2,300	$ 1,997
Stockholders' equity (Textuals) [Abstract]
Additional amount authorized under stock repurchase plan							$ 5,000
Amount available for stock repurchases under a board approved stock repurchase plan	$ 3,700				$ 3,700

Fair value measurement (Details) - USD ($) $ in Millions	Jun. 30, 2010	Dec. 31, 2009
Assets
Total available-for-sale securities	$ 14,449	$ 13,397
Total derivatives	542	153
Total assets	14,991	13,550
Liabilities
Total derivatives	46	152
Total liabilities	46	152
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Convertible notes current	2,414	0
Convertible notes	2,232	4,512
Notes payable	7,086	6,089
Notes payable, fair value	13,210	11,649
Total borrowings	11,732	10,601
Fair value measurement (Textuals) [Abstract]
Interest rate swap open agreements - fair value hedges - notional amount	2,600	1,500
Foreign currency forward contracts [Member]
Fair value measurement (Textuals) [Abstract]
Foreign currency open contracts - cash flow hedges - notional amounts	3,200	3,400
Foreign currency open contracts - not designated as hedges - notional amounts	566	414
Foreign currency option contracts [Member]
Fair value measurement (Textuals) [Abstract]
Foreign currency open contracts - cash flow hedges - notional amounts	419	376
Foreign exchange contracts [Member]
Assets
Total derivatives	328
Liabilities
Total derivatives	46
Interest Rate Swap Contracts [Member]
Assets
Total derivatives	214
US Treasury securities [Member]
Assets
Total available-for-sale securities	3,831	1,935
Obligations of U.S. government agencies and FDIC guaranteed bank debt [Member]
Assets
Total available-for-sale securities	2,906	3,792
Other government related debt securities - Foreign and other [Member]
Assets
Total available-for-sale securities	998
Total other government related debt securities [Member]
Assets
Total available-for-sale securities	3,904
Corporate debt securities [Member]
Assets
Total available-for-sale securities	4,171	4,285
Corporate debt securities - Financial [Member]
Assets
Total available-for-sale securities	1,715
Corporate debt securities - Industrial [Member]
Assets
Total available-for-sale securities	2,169
Corporate debt securities - Other [Member]
Assets
Total available-for-sale securities	287
Total debt securities [Member]
Assets
Total available-for-sale securities	14,408	13,342
Mortgage and asset backed securities [Member]
Assets
Total available-for-sale securities	705	491
Money market mutual funds [Member]
Assets
Total available-for-sale securities	1,544	2,784
Other short-term interest bearing securities [Member]
Assets
Total available-for-sale securities	253	55
Equity securities [Member]
Assets
Total available-for-sale securities	41	55
0.125% convertible notes due February 2011 (2011 Convertible notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Convertible notes current	2,414
Convertible notes		2,342
Convertible notes payable, fair value	2,491	2,487
0.375% convertible notes due 2013 (2013 Convertible notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Convertible notes	2,150	2,088
Convertible notes payable, fair value	2,451	2,374
5.85% notes due 2017 (2017 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	1,099	1,099
Notes payable, fair value	1,275	1,207
4.85% notes due 2014 (2014 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	1,000	1,000
Notes payable, fair value	1,116	1,075
5.70% notes due 2019 (2019 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	998	998
Notes payable, fair value	1,160	1,077
6.40% notes due 2039 (2039 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	996	995
Notes payable, fair value	1,175	1,102
6.375% notes due 2037 (2037 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	899	899
Notes payable, fair value	1,036	988
5.75% notes due 2040 (2040 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	696	0
Notes payable, fair value	761
6.15% notes due 2018 (2018 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	499	499
Notes payable, fair value	587	551
6.90% notes due 2038 (2038 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	499	499
Notes payable, fair value	619	582
Zero-coupon modified convertible notes due in 2032 (2032 Modified convertible notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Convertible notes	82	82
Convertible notes payable, fair value	83	81
8.125% notes due 2097 (Other) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	100	100
Notes payable, fair value	135	125
4.50% notes due 2020 (2020 Notes) [Member]
Carrying value and estimated fair value of our convertible notes, modified convertible notes and other notes payable
Notes payable	300	0
Notes payable, fair value	321
Quoted prices in active markets for identical assets (Level 1) [Member]
Liabilities
Total derivatives	0	0
Total liabilities	0	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Foreign exchange contracts [Member]
Liabilities
Total derivatives	0
Significant other observable inputs (Level 2) [Member]
Liabilities
Total derivatives	46	152
Total liabilities	46	152
Significant other observable inputs (Level 2) [Member] \| Foreign exchange contracts [Member]
Liabilities
Total derivatives	46
Significant unobservable inputs (Level 3) [Member]
Liabilities
Total derivatives	0	0
Total liabilities	0	0
Significant unobservable inputs (Level 3) [Member] \| Foreign exchange contracts [Member]
Liabilities
Total derivatives	0
Quoted prices in active markets for identical assets (Level 1) [Member]
Assets
Total available-for-sale securities	5,416	4,774
Total derivatives	0	0
Total assets	5,416	4,774
Quoted prices in active markets for identical assets (Level 1) [Member] \| Foreign exchange contracts [Member]
Assets
Total derivatives	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Interest Rate Swap Contracts [Member]
Assets
Total derivatives	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| US Treasury securities [Member]
Assets
Total available-for-sale securities	3,831	1,935
Quoted prices in active markets for identical assets (Level 1) [Member] \| Obligations of U.S. government agencies and FDIC guaranteed bank debt [Member]
Assets
Total available-for-sale securities	0	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Other government related debt securities - Foreign and other [Member]
Assets
Total available-for-sale securities	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Total other government related debt securities [Member]
Assets
Total available-for-sale securities	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Corporate debt securities [Member]
Assets
Total available-for-sale securities	0	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Corporate debt securities - Financial [Member]
Assets
Total available-for-sale securities	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Corporate debt securities - Industrial [Member]
Assets
Total available-for-sale securities	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Corporate debt securities - Other [Member]
Assets
Total available-for-sale securities	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Mortgage and asset backed securities [Member]
Assets
Total available-for-sale securities	0	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Money market mutual funds [Member]
Assets
Total available-for-sale securities	1,544	2,784
Quoted prices in active markets for identical assets (Level 1) [Member] \| Other short-term interest bearing securities [Member]
Assets
Total available-for-sale securities	0	0
Quoted prices in active markets for identical assets (Level 1) [Member] \| Equity securities [Member]
Assets
Total available-for-sale securities	41	55
Significant other observable inputs (Level 2) [Member]
Assets
Total available-for-sale securities	9,033	8,623
Total derivatives	542	153
Total assets	9,575	8,776
Significant other observable inputs (Level 2) [Member] \| Foreign exchange contracts [Member]
Assets
Total derivatives	328
Significant other observable inputs (Level 2) [Member] \| Interest Rate Swap Contracts [Member]
Assets
Total derivatives	214
Significant other observable inputs (Level 2) [Member] \| US Treasury securities [Member]
Assets
Total available-for-sale securities	0	0
Significant other observable inputs (Level 2) [Member] \| Obligations of U.S. government agencies and FDIC guaranteed bank debt [Member]
Assets
Total available-for-sale securities	2,906	3,792
Significant other observable inputs (Level 2) [Member] \| Other government related debt securities - Foreign and other [Member]
Assets
Total available-for-sale securities	998
Significant other observable inputs (Level 2) [Member] \| Total other government related debt securities [Member]
Assets
Total available-for-sale securities	3,904
Significant other observable inputs (Level 2) [Member] \| Corporate debt securities [Member]
Assets
Total available-for-sale securities	4,171	4,285
Significant other observable inputs (Level 2) [Member] \| Corporate debt securities - Financial [Member]
Assets
Total available-for-sale securities	1,715
Significant other observable inputs (Level 2) [Member] \| Corporate debt securities - Industrial [Member]
Assets
Total available-for-sale securities	2,169
Significant other observable inputs (Level 2) [Member] \| Corporate debt securities - Other [Member]
Assets
Total available-for-sale securities	287
Significant other observable inputs (Level 2) [Member] \| Mortgage and asset backed securities [Member]
Assets
Total available-for-sale securities	705	491
Significant other observable inputs (Level 2) [Member] \| Money market mutual funds [Member]
Assets
Total available-for-sale securities	0	0
Significant other observable inputs (Level 2) [Member] \| Other short-term interest bearing securities [Member]
Assets
Total available-for-sale securities	253	55
Significant other observable inputs (Level 2) [Member] \| Equity securities [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member]
Assets
Total available-for-sale securities	0	0
Total derivatives	0	0
Total assets	0	0
Significant unobservable inputs (Level 3) [Member] \| Foreign exchange contracts [Member]
Assets
Total derivatives	0
Significant unobservable inputs (Level 3) [Member] \| Interest Rate Swap Contracts [Member]
Assets
Total derivatives	0
Significant unobservable inputs (Level 3) [Member] \| US Treasury securities [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member] \| Obligations of U.S. government agencies and FDIC guaranteed bank debt [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member] \| Other government related debt securities - Foreign and other [Member]
Assets
Total available-for-sale securities	0
Significant unobservable inputs (Level 3) [Member] \| Total other government related debt securities [Member]
Assets
Total available-for-sale securities	0
Significant unobservable inputs (Level 3) [Member] \| Corporate debt securities [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member] \| Corporate debt securities - Financial [Member]
Assets
Total available-for-sale securities	0
Significant unobservable inputs (Level 3) [Member] \| Corporate debt securities - Industrial [Member]
Assets
Total available-for-sale securities	0
Significant unobservable inputs (Level 3) [Member] \| Corporate debt securities - Other [Member]
Assets
Total available-for-sale securities	0
Significant unobservable inputs (Level 3) [Member] \| Mortgage and asset backed securities [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member] \| Money market mutual funds [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member] \| Other short-term interest bearing securities [Member]
Assets
Total available-for-sale securities	0	0
Significant unobservable inputs (Level 3) [Member] \| Equity securities [Member]
Assets
Total available-for-sale securities	$ 0	$ 0

Derivative instruments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Derivative instruments (Details) - USD ($) $ in Millions	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2010	Jun. 30, 2009	Dec. 31, 2009
Location in the Consolidated Statements of Income and effective portion of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income for our cash flow hedge contracts
Total	$ 21	$ 10	$ 15	$ 29
Derivative instruments (Textuals) [Abstract]
Length of time hedged in foreign currency cash flow hedge			3
Ineffective portions of cash flow hedging instruments (approximately)	1		$ 1
Ineffective portions of cash flow hedging instruments (approximately)		1		1
Interest rate swap open agreements - fair value hedges - notional amount	2,600		2,600		$ 1,500
Unrealized gain (loss) on the hedged debt	(107)	41	(124)	103
Offsetting unrealized gain (loss) on related interest rate swaps	107	(41)	124	(103)
Assets
Total derivatives designated as hedging instruments	542		542		153
Total derivatives not designated as hedging instruments	0		0		0
Total derivatives	542		542		153
Liabilities
Total derivatives designated as hedging instruments	46		46		152
Total derivatives not designated as hedging instruments	0		0		0
Total derivatives	46		46		152
Foreign currency forward and option contracts [Member]
Derivative instruments (Textuals) [Abstract]
Amounts expected to be reclassified from accumulated other comprehensive income into income over the next 12 months - gain (loss)	130		130
Foreign currency option contracts [Member]
Derivative instruments (Textuals) [Abstract]
Foreign currency open contracts - cash flow hedges - notional amounts	419		419		376
Foreign currency forward contracts [Member]
Derivative instruments (Textuals) [Abstract]
Foreign currency open contracts - cash flow hedges - notional amounts	3,200		3,200		3,400
Foreign currency open contracts - not designated as hedges - notional amounts	566		566		$ 414
Forward interest rate contracts [Member]
Location in the Consolidated Statements of Income and effective portion of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income for our cash flow hedge contracts
The amount of gain (loss) recognized in interest expense, net	0	0	0	0
Derivative instruments (Textuals) [Abstract]
Amounts expected to be reclassified from accumulated other comprehensive income into income over the next 12 months - gain (loss)	(1)		(1)
Foreign exchange contracts [Member]
Location in the Consolidated Statements of Income and effective portion of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income for our cash flow hedge contracts
The amount of gain (loss) recognized in product sales	21	10	15	29
Foreign exchange contracts [Member] \| Interest and other income [Member]
Location in the Consolidated Statements of Income and the amount of gain recognized in income for the derivative instruments not designated as hedging instruments
Derivatives not designated as hedging instruments	53	(10)	76	4
Cash flow hedging [Member]
Effective portion of the unrealized gain/(loss) recognized in other comprehensive income for our cash flow hedge contracts
Unrealized gain (loss) on derivative instruments recognized in other comprehensive income, effective portion, net	224	(100)	399	(88)
Cash flow hedging [Member] \| Forward interest rate contracts [Member]
Effective portion of the unrealized gain/(loss) recognized in other comprehensive income for our cash flow hedge contracts
Unrealized gain (loss) on derivative instruments recognized in other comprehensive income, effective portion, net	0	0	0	(11)
Cash flow hedging [Member] \| Foreign exchange contracts [Member]
Effective portion of the unrealized gain/(loss) recognized in other comprehensive income for our cash flow hedge contracts
Unrealized gain (loss) on derivative instruments recognized in other comprehensive income, effective portion, net	$ 224	$ (100)	$ 399	$ (77)

Label	Element	Value
Other current assets [Member] \| Foreign exchange contracts [Member]
Derivative Asset Not Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue	$ 0
Derivative Asset Not Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue	0
Accrued liabilities/other noncurrent liabilities [Member] \| Interest rate swap contracts [Member]
Derivative Liability Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeLiabilityDesignatedAsHedgingInstrumentFairValue	0
Derivative Liability Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeLiabilityDesignatedAsHedgingInstrumentFairValue	0
Accrued liabilities/other noncurrent liabilities [Member] \| Foreign exchange contracts [Member]
Derivative Liability Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeLiabilityDesignatedAsHedgingInstrumentFairValue	152,000,000
Derivative Liability Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeLiabilityDesignatedAsHedgingInstrumentFairValue	46,000,000
Other current assets/other non-current assets [Member] \| Interest rate swap contracts [Member]
Derivative Asset Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeAssetDesignatedAsHedgingInstrumentFairValue	90,000,000
Derivative Asset Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeAssetDesignatedAsHedgingInstrumentFairValue	214,000,000
Other current assets/other non-current assets [Member] \| Foreign exchange contracts [Member]
Derivative Asset Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeAssetDesignatedAsHedgingInstrumentFairValue	63,000,000
Derivative Asset Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeAssetDesignatedAsHedgingInstrumentFairValue	328,000,000
Accrued Liabilities[ Member] \| Foreign exchange contracts [Member]
Derivative Liability Not Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue	0
Derivative Liability Not Designated as Hedging Instrument, Fair Value	us-gaap_DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue	$ 0